Finanzas de BIO-Key International Inc (BKYI)BKYIBIO-Key International Inc

BIO-Key International Inc (BKYI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is License fees, accounting for 63.7% of total sales, equivalent to $1.37M. Other significant revenue streams include Hardware and Services. Understanding this composition is critical for investors evaluating how BKYI navigates market cycles within the Electronic Equipment & Parts industry.

Evaluating the bottom line, BIO-Key International Inc maintains a gross margin of 87.19%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -27.57%, while the net margin is -30.04%. These profitability ratios, combined with a Return on Equity (ROE) of -107.91%, provide a clear picture of how effectively BKYI converts its operational activities into shareholder value.

In the context of the broader market, BKYI competes directly with industry leaders such as HTCR and DTST. With a market capitalization of $4.45M, it holds a significant position in the sector. When comparing efficiency, BKYI's gross margin of 87.19% stands against HTCR's -21.84% and DTST's 46.99%. Such benchmarking helps identify whether BIO-Key International Inc is trading at a premium or discount relative to its financial performance.

The company's gross margin is strong at 87.19% for Q2 2026, but it continues to report net losses, with a net income of -576,852 USD in the same quarter.